[ad_1]
Feverish vaccination and drug studies continue against the corona virus, which infects more than 55.9 million people around the world and killed 1.3 million …
The first results of the vaccine called CoronaVac, developed by the Chinese company called Sinovac Biotech, which acted before other countries in vaccination, were shared today with the public. Last week, with the vaccine developed by Pfizer and BioNTech, the effectiveness rate of the vaccines developed by Moderna and the Russians, based in the United States was reached, while the vaccine developed by Sinovac Biotech only shared the results of the first and second phase.
PROTECTION FUNCTION
Authorities, who published the results of the vaccine called CoronaVac in peer-reviewed journals, announced that the vaccine responded quickly to the immune system. However, the level of antibodies produced by the vaccine was claimed to be low. The experts also claimed that the vaccine may have a protective function. Turkey, Indonesia, and if the vaccine is effective, it continues to work in Brazil in the last phase of the work will be revealed.
Evaluating the data published in the Lancet Infectious Diseases and directing the vaccine studies, Zhu Fengcai said: “We have seen the results that CoronaVac rapidly strengthens the immune system in four weeks by administering two doses over a 14-day period. We believe that this vaccine can be used as an emergency during the epidemic, ”he said.
MORE RESISTANT TO HEAT
Studies of CoronaVac, one of the 3 vaccines included in the emergency use program in China, have been announced to continue. It was announced that the two vaccines previously developed in China achieved similar results, but the third phase is expected.
Making a statement on CoronaVac, expert Gang Zeng said: “Our CoronaVac vaccine will be more attractive than other alternatives. Because it can be stored in normal refrigerators. It can last from 2 to 8 degrees and has a shelf life of three years. In other vaccines, it must be stored in extreme cold, ”he said.
The vaccines developed by Pfizer / BioNTech and Moderna should be kept at minus 70 and minus 20 degrees.
It may interest you
[ad_2]
